Label: VEXASYN-

  • NHRIC Code(s): 69336-831-01
  • Packager: Sterling-Knight Pharmaceuticals, LLC
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Premarket Notification

Drug Label Information

Updated July 31, 2018

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Vexasyn is a soothing wound gel that promotes a moist wound environment that is ideal for the healing process.

  • Directions:

    Cleanse wound then apply Vexasyn to the wound and skin surrounding the wound 3 - 4 times daily.

  • Indications:

    For the local management of painful skin wounds, including:
    • Pressure ulcers
    • Venus stasis ulcers
    • Superficial wounds and scrapes
    • 1st and 2nd degree burns

  • Warnings:

    External use only. Do not use this product if you are allergic to any of the ingredients. Avoid contact with eyes. Sterile unless opened or damaged.

  • Caution:

    Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.

  • Storage:

    Store at 25°C (77°F): excursions permitted to 15°-30°C (59°-86°F). Protect from freezing [See USP Controlled Room Temperature].

  • Ingredients:

    Ingredients: Water, Lidocaine HCl, Collagen, Aloe Vera gel, Sodium alginate, Glycerin, Hydroxyethylcellulose, Triethanolamine, Benzethonium chloride.

  • SPL UNCLASSIFIED SECTION

    CALL YOUR DOCTOR ABOUT SIDE EFFECTS.
    Call your doctor about side effects. You may report side effects to Sterling Knight Pharmaceuticals, LLC at 1-888-460-1531 or the FDA at 1-800-FDA-1088.

  • How Supplied

    Vexasyn wound gel is supplied as a gel in:
    1 oz. (28.33g) tube, NDC 69336-831-01

  • SPL UNCLASSIFIED SECTION

    Distributed By:
    Sterling-Knight Pharmaceuticals, LLC
    Ripley, MS 38663


    Rev 121517-1

  • Principal Display Panel

    vexaimage

  • INGREDIENTS AND APPEARANCE
    VEXASYN 
    dressing, wound and burn, hydrogel w/drug and/or biologic
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NHRIC:69336-831
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A)  
    SODIUM ALGINATE (UNII: C269C4G2ZQ)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%) (UNII: R33S7TK2EP)  
    TROLAMINE (UNII: 9O3K93S3TK)  
    BENZETHONIUM CHLORIDE (UNII: PH41D05744)  
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    BOVINE TYPE I COLLAGEN (UNII: FHJ3ATL51C)  
    Product Characteristics
    (SPLSTERILEUSE)false
    (SPLMRISAFE)true
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NHRIC:69336-831-0128.33 g in 1 BOTTLE; Type 0: Not a Combination Product01/02/2018
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    premarket notificationK02054001/01/2017
    Labeler - Sterling-Knight Pharmaceuticals, LLC (079556942)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sterling-Knight Pharmaceuticals, LLC079556942label(69336-831) , analysis(69336-831)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!